Recombinant Human B7-1/CD80 (hFc Tag)

Scan for product

HEK293细胞表达系统免疫检查点研究共刺激通路研究

Product no.93545ES Sizes4 options SourceYeasen · Official

Cat. No. 93545ES20

现货 ¥985.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

93545ES20 20 μg ¥985.00 现货 Enquire

93545ES60 100 μg ¥3,385.00 现货 Enquire

93545ES76 500 μg ¥11,305.00 现货 Enquire

93545ES80 1 mg ¥21,475.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No93545ES

Specification高纯度、高活性、低内毒素、高批间一致性

Origin翌圣生物科技(上海)股份有限公司

技术平台 HEK293细胞表达系统

应用方法 免疫检查点研究B7-1/CD80是共刺激通路关键分子，用于免疫调节研究 共刺激通路研究调控T/B细胞反应

适用物种种属人

检测方法 ELISA SDS-PAGE HPLC LAL法

生物特性参数 蛋白类型重组蛋白/靶点蛋白/免疫检查点 种属来源Human 生物活性描述Immobilized Human B7-1 hFc Tag at 0.5μg/ml (100μL/Well) on the plate. Dose response curve for Human CTLA-4 His Tag with the EC50 of 66ng/ml determined by ELISA 应用B7-1/CD80与B7-2/CD86及其受体CD28和CTLA-4构成共刺激通路，调节T/B细胞反应；CTLA-4与B7-1结合亲和力高于CD28，参与免疫反应下调

技术参数纯度>95% as determined by SDS-PAGE and HPLC 内毒素水平<1.0 EU per μg by the LAL method 分子量Predicted MW 50.5 kDa migrates to 70-80 kDa due to glycosylation (Tris-Bis PAGE) 制剂形式Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization 活性ELISA Data: Immobilized Human B7-1 hFc Tag at 0.5μg/ml (100μL/Well) on the plate. Dose response curve for Human CTLA-4 His Tag with the EC50 of 66ng/ml determined by ELISA 储存条件-25 ~ -15℃保存，收到货后有效期1年；复溶后，无菌条件下，-85 ~ -65℃保存，3个月有效期 表达序列Val35-Asn242 表达系统HEK293 标签C-hFc 复溶方法开盖前先离心；使用蒸馏水复溶冻干蛋白，复溶浓度超过100 μg/mL；建议首次使用时分装，避免反复冻融 外观Lyophilized Powder AccessionP33681-1 产品别称CD80 molecule B7 B71 B7-1 BB1 CD28LG1 CD80 B7.1 CD28LG1 LAB7